These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20833867)

  • 41. Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes.
    Montvida O; Green JB; Atherton J; Paul SK
    Diabet Med; 2019 Apr; 36(4):491-498. PubMed ID: 30306620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type 2 diabetes mellitus and the risk of acute pancreatitis: a meta-analysis.
    Yang L; He Z; Tang X; Liu J
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):225-31. PubMed ID: 23269036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
    Brauer R; Wei L; Ma T; Athauda D; Girges C; Vijiaratnam N; Auld G; Whittlesea C; Wong I; Foltynie T
    Brain; 2020 Oct; 143(10):3067-3076. PubMed ID: 33011770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study.
    Abu-Ashour W; Chibrikova L; Midodzi WK; Twells LK; Gamble JM
    Diabet Med; 2017 Feb; 34(2):229-234. PubMed ID: 26802577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between Gout and Diabetes Mellitus after Acute Pancreatitis: A Nationwide Cohort Study.
    Cho J; Dalbeth N; Petrov MS
    J Rheumatol; 2020 Jun; 47(6):917-923. PubMed ID: 31615915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study.
    Thomsen RW; Pedersen L; Møller N; Kahlert J; Beck-Nielsen H; Sørensen HT
    Diabetes Care; 2015 Jun; 38(6):1089-98. PubMed ID: 25633664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study.
    Kuo S; Yang CT; Wu JS; Ou HT
    Diabetes Obes Metab; 2019 Feb; 21(2):312-320. PubMed ID: 30187666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes.
    Min JY; Griffin MR; Hung AM; Grijalva CG; Greevy RA; Liu X; Elasy T; Roumie CL
    J Gen Intern Med; 2016 Jun; 31(6):638-46. PubMed ID: 26921160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
    Chen CH; Lin CL; Hsu CY; Kao CH
    QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Childhood Pancreatitis and Risk for Incident Diabetes in Adulthood.
    Bendor CD; Bardugo A; Zucker I; Cukierman-Yaffe T; Lutski M; Derazne E; Shohat T; Mosenzon O; Tzur D; Sapir A; Pinhas-Hamiel O; Kibbey RG; Raz I; Afek A; Gerstein HC; Tirosh A; Twig G
    Diabetes Care; 2020 Jan; 43(1):145-151. PubMed ID: 31694859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. National trends in incidence and outcomes of acute pancreatitis among type 2 diabetics and non-diabetics in Spain (2001-2011).
    Méndez-Bailón M; de Miguel Yanes JM; Jiménez-García R; Hernández-Barrera V; Pérez-Farinós N; López-de-Andrés A
    Pancreatology; 2015; 15(1):64-70. PubMed ID: 25500341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality.
    Mendez CE; Walker RJ; Eiler CR; Mishriky BM; Egede LE
    Postgrad Med; 2019 Aug; 131(6):376-382. PubMed ID: 31311382
    [No Abstract]   [Full Text] [Related]  

  • 54. GLP-1 receptor agonists and pancreatic safety concerns in type 2 diabetic patients: data from cardiovascular outcome trials.
    Cao C; Yang S; Zhou Z
    Endocrine; 2020 Jun; 68(3):518-525. PubMed ID: 32103407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity.
    Peeters PJ; Bazelier MT; Leufkens HG; de Vries F; De Bruin ML
    Diabetes Care; 2015 Mar; 38(3):495-502. PubMed ID: 25552419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
    Juhaeri J; Gao S; Dai WS
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):497-503. PubMed ID: 19326365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.
    Bruno G; Merletti F; Boffetta P; Cavallo-Perin P; Bargero G; Gallone G; Pagano G
    Diabetologia; 1999 Mar; 42(3):297-301. PubMed ID: 10096781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An acute edematous pancreatitis case developed on the basis of hypertriglyceridemia.
    Aslan T; Erden A; Karagoz H; Karahan S; Aykas F; Uslu E; Mutlu H; Karaman A
    Med Arch; 2013; 67(4):295-6. PubMed ID: 24520759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection.
    Kawaguchi T; Taniguchi E; Morita Y; Shirachi M; Tateishi I; Nagata E; Sata M
    Liver Int; 2010 Mar; 30(3):479-86. PubMed ID: 20040053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases.
    Bosetti C; Franchi M; Nicotra F; Asciutto R; Merlino L; La Vecchia C; Corrao G
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):771-8. PubMed ID: 26013675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.